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ABSTRACT 
Objective: The present investigation was aimed towards developing calcium crosslinked derivative of carboxymethylated cassia fistula gum and 
crosscarmellose sodium based orodispersible tablets (ODTs) of propranolol hydrochloride for enhancing the bioavailability and efficacy.  
Methods: Orodispersible tablets (ODTs) of propranolol hydrochloride was formulated using natural (a carboxymethylated derivative of cassia 
fistula gum) and synthetic polymer (crosscarmellose sodium) by wet and dry granulation, lyophilization and cotton candy methods and then finally 
compressed by direct compression. The prepared ODTs were evaluated for several parameters such as hardness, friability, in vitro disintegration 
time, in vitro drug release. In vivo and stability studies were carried out on optimized formulation coding PC1. 
Results: Drug polymer interaction were judged by FT-IR, DSC and XRD. The optimized formulation coding PC1 prepared by cotton candy process 
containing 2.5% w/w of crosslinked cassia fistula gum has the least disintegration time (18.9±0.4s), weeting time (12.5±0.8s) and relased the drug 
of 88.2% within 10 min in contrast to croscarmellose sodium. In vivo absorption studies revealed that same formulation has Cmax (µg/ml) 2.13±0.73, 
tmax (h) 0.21±0.17 and AUC0
∞(µg ml-1 h-1
Conclusion: This research manuscript clearly shows the successful development of the ODTs loaded with an antihypertensive drug, namely 
propranolol hydrochloride. The formulation developed by cotton candy process utilizing crosslinked cassia fistula gum as a natural 
superdisintegrant in contrast to other existing techniques can be a best option over synthetic superdisintegrant i.e. crosscarmellose sodium. The 
prepared ODTs was enhanced the absorption rate by lowering t
) 14.33±1.59. 
max,
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 which inturn enhance the bioavailability and the efficacy of drug. 
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INTRODUCTION 
Oral route of drug administration is the most common, natural and 
obvious route to introduce the drug in the biological system. It is 
simple and convenient route offering maximum patient compliance 
and least medical supervision [1]. It is the best suited route for the 
drugs offering moderate to higher bioavailability and exhibiting 
varying pKavalues though the bioavailability varies a lot by this route 
[2]. The pH of the gastrointestinal tract (GIT) varies; hence the drugs 
with a range of pKa and solubilities are best suited to be administered 
by this route [3]. Also, this route offers an added advantage of the 
administration of huge doses, which is almost impossible with other 
routes. However, there are many challenges to have a predictable and 
dependable bioavailability and pharmacokinetic profile from this very 
route. The major factors constituting the challenging barriers and 
posing hurdles include, but not limited to the pH variability, intestinal 
mobility, gastric emptying time, hepatic and intestinal metabolism [4]. 
With an aim to design easily administrable drug products, newer 
tablets have been developed by pharmaceutical manufacturers, which 
can be simply placed and tongue and disintegrate/dissolve when come 
in contact with saliva. These systems eliminate the need of chewing 
and use of water for the ingestion of such oral products. Apart from 
numerous benefits, these oral tablets have been proved to be 
beneficial for paediatric, geriatric and psychiatric patients. As these 
systems can easily form solutions or dispersions within a fraction of 
min and the drug particles are exposed to the highly vascular oral 
cavity, there is substantial absorption of the drug, which is not feasible 
with the conventional oral dosing. Meanwhile, there are no choking 
hazards and miniscule chances of sticking and obstruction of the food 
passage, these systems are far safer than the other comparable 
oral/peroral products. Henceforth, ODTs are regarded as the systems 
which enhance the safety as well as efficacy of the drugs administered 
by this technique [5]. Propranolol hydrochloride is a β-adrenoreceptor 
antagonist, which inhibits the orthosympathetic pathways by 
competing with the catecholamines. It is use to control hypertension 
by targeting the peripheral sites of the non-adrenergic systems. This 
drug is also used for the treatment of tachyarrhythmia and coronary 
artery disease. Even though this drug is potent, there are certain side 
effects preventing its wide applications. They include excessive hepatic 
metabolism, low bioavailability of 25%. In order to overcome all these 
factors produced by the conventional tablets, it was planned to 
prepare calcium crosslinked cassia fistula gum (CCG) based 
orodispersible propranolol hydrochloride tablets along with its 
exploration through various evaluation parameters.  
MATERIALS AND METHODS 
Materials 
Propranolol hydrochloride and crosscarmellose sodium was kindly 
supplied by Tidal Laboratories Pvt. Ltd, Himachal Pradesh, India. 
Seeds of cassia fistula were procured from Sugatu Global, Uttarakhand, 
India. PEG 400 and Hydroxypropyl methylcellulose (HPMC) were 
purchased from M/s Sigma-Aldrich, Bangalore, India. M/s Central 
Drug House, New Delhi, India supplied lactose, gelatin, talc, buffer 
reagents, mannitol, magnesium stearate and polyvinyl pyrrolidine. The 
solvents and the column [Oyster BDS premium C18 (250 x 4.6, 5 µm; 
Batch No: 43/053)] employed for the HPLC were procured from M/s 
Merck Specialities Pvt. Ltd., Mumbai, India. In all the protocols where 
ever there is a need, double distilled water was employed. All chemical 
procured are used as such without any other purification.  
Methods 
Extraction of cassia fistula gum 
Plants of cassia fistula is widely distributed in India except for 
Jammu and Kashmir, Himachal Pradesh, Maharashtra, Odisha and 
Uttar Pradesh. For the present study, seeds were procured from the 
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authentic source-Sugatu Global [voucher no. SG-2018/04/05 dated 
05/04/2018], Uttarakhand, India. The botanical identity of the plant 
was confirmed by Dr. Deepak Kumar Associate Professor from 
ACPTE, Mastuana Sahib, Sangrur, Punjab with ref. no. 
ACPTE/PG/PA-990 dated 02/05/2019. 
Seeds kernel powder of cassia fistula (20 g) were used for the 
extraction of the gum. The powder slurry was prepared by soaking the 
powder in 200 ml of cold distilled water. To this slurry, 800 ml of 
boiling distilled water was added, subsequently boiled for 20 min 
using a water bath assisted with continuous stirring. The boiling was 
stopped after the scheduled time period and the system was left 
undisturbed for overnight to facilitate the sedimentation of protein 
and fibres. The clear supernatant was harvested after centrifugation 
for 20 min at 5000 rpm. The precipitation of the polysaccharides was 
completed by pouring the supernatant in the twice volume of ethanol 
while stirring. The obtained precipitate was washed sequentially with 
ethanol, diethyl ether and petroleum ether followed by drying at 40-45 
°C. The final product was sifted through sieve number 120 and 
desiccated till further use [6-8]. Analytical techniques like FT-IR and 
NMR were employed to characterize the gum. 
Carboxymethylation of cassia fistula gum 
The previously reported method by Goyal et al. was employed to 
derivatize cassia fistula gum to carboxymethylated cassia fistula gum 
(CCG) [9]. The extracted gum (5g) was suspended in 16 ml of 11.25 
M NaOH solution, maintained at 1-4 °C. After complete dispersion, 7 
ml of 7.93 M chloroacetic acid was added with stirring. The stirring 
was continued for 1 h at ambient temperature. After 1 h, the 
temperature was raised to 75 °C and the system was further stirred 
for 30 min. A solution of methanol and water in the volume ratio of 
8:2 was prepared and neutralized by adding ethanoic acid. The 
reaction mixture was cooled and added into the methanolic solution 
to precipitate the CCG and the precipitates were collected on muslin 
cloth. The filtrate was washed thrice with the neutralized 
methanolic solution and the harvested solid was dried for 4 h at 50 
°C and sifted across sieve number 80. The final product was vacuum 
desiccated till further use [7]. 
Preparation of calcium cross-linked CCG 
The calcium cross-linked derivative of CCG was prepared by method 
reported by Rai et al. [7]. The CCG (2.5 g) was dispersed in 50 ml of 
deionized water to fetch 5% w/v dispersion. To this dispersion, 50 ml 
of 0.45 M calcium chloride was added dropwise assisted with constant 
stirring, followed by dropwise addition of 50 ml of isopropyl alcohol. 
The thick and gelatinous mass of the calcium cross-linked CCG was 
harvested and washed with deionized water to remove the unreacted 
CCG. The endpoint of the washings was determined by the 
disappearance of red colour of the filtrate when mixed with standard 
magnesium–EDTA complex solution containing Eriochrome black T 
indicator solution. The precipitates were freeze-dried and passed from 
sieve number 80 and desiccated till further use. 
Development and optimization of orodispersible tablets 
For the development of ODTs of propranolol hydrochloride three 
methods of preparation viz. lyophilization method, cotton candy 
process and disintegrant addition technique. 
Lyophilization method 
Formula was developed in such a way that each tablet contains 10 
mg of propranolol hydrochloride each with different amounts of 
binder and disintegrants, as shown in table 1. A total of 8 
formulations were developed where the percentages of the binder 
(gelatin) and the disintegrant (cassia fistula gum) were kept fixed 
and the amount of the diluent, i.e. mannitol, was varied. 
 
Table 1: Composition of orodispersible propranolol hydrochloride tablets developed by lyophilization method 
Materials LP1 LP2 LP3 LP4 LP5 LP6 LP7 LP8 
Propranolol hydrochloride (mg) 10  10 10  10  10  10  10  10  
Mannitol (mg)  210  300  350  400  210  300  350  400  
Gelatin (%) 1 1 1 1 1 1 1 1 
Cross linked cassia fistula gum*CCG (%) - - - - 2.5 2.5 2.5 2.5 
Croscarmellose sodium*CCS (%) 2.5 2.5 2.5 2.5 - - - - 
 *CCG= cross linked cassia fistula gum *CCS= croscarmellose Sodium 
 
Propranolol hydrochloride, crosslinked cassia fistula 
gum/croscarmellose sodium and mannitol were weighed 
accordingly and added to warm gelatin solution. The solution was 
blended vigorously to form stable suspension. Obtained suspension 
was filled into the blisters of diameter 13 mm by a syringe and was 
kept at-40 °C for 3 h. Blisters were transferred into a freeze dryer 
and was dried for 48 h at a temperature of-55 °C and pressure of 18 
mTorr. No cryoprotectant was added additionally due to the 
presence of mannitol in the system itself [10, 11]. 
Cotton candy process 
Two formulas for the tablets developed by the cotton candy process 
were used with only the variation of the superdisintegrants, viz. CCG 
and CCS both at the same strength. As already disclosed, the amount 
of propranolol hydrochloride per tablet was 10 mg for each of the 
tablet. The method reported by Battist et al. was employed for the 
development of the two formulations [12]. Firstly, a shear form 
matrix was prepared, which comprised of 82.25% sucrose, 15% 
sorbitol, 2.5% CCG/CCS and 0.25% Tween 60. All the ingredients 
were handed mixed and then mixed mechanically. The floss was 
prepared using a floss machine at approximately 3000 rpm. The 
floss was chopped and further used. The tablet mixture was 
prepared using 4.5% propranolol hydrochloride, 2.5% CCG/CCS, 
0.3% aspartame, 2.5% orange flavour, 0.5% PEG 400 and q. s. floss. 
The ingredients were properly mixed and for each tablet, 225 mg of 
the mixture was weighed and introduced in the mould of approx. 
0.25 inches. The ingredients were tamped at 80 psi pressure and 
cured at 40 °C and 85% RH for 15 min.  
Disintegrant addition method 
Formulation of propranolol hydrochloride orodispersible tablets by 
granulation methods is shown in table 2. 
 
Table 2: Composition of the orodispersible tablets of propranolol hydrochloride prepared by disintegrant addition method 
Materials F1 F2 F3 F4 F5 F6 
Propranolol hydrochloride (mg) 10  10 10 10  10 10 
Cross linked cassia fistula gum (mg) 20 20 20 - - - 
Croscarmellose sodium (mg) - - - 20 20 20 
Hydroxypropyl cellulose (mg) - - 2 - - 2 
Polyvinyl pyrrolidone (mg) - 2 - - 2 - 
Starch (mg) 2 - - 2 - - 
Microcrystalline cellulose (mg) 33.5 33.5 33.5 33.5 33.5 33.5 
Lactose (mg) 28 28 28 28 28 28 
Magnesium stearate 1.5 1.5 1.5 1.5 1.5 1.5 
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Preparation of tablets by wet granulation method 
Granules as per the composition disclosed in table 2 were prepared by 
mixing the drug with starch paste which acts as binder. The wet mass 
was passed through # 10 and dried for 24 h at 60 °C followed by passing 
through 20 mesh sieves. Tablets are prepared by compression in the 
presence of super disintegrants. Known amounts of granules were 
weighed and mixed with cross-linked cassia fistula gum/croscarmellose 
sodium and other ingredients for 10-15 min using blender. To this 
mixture, lactose and magnesium stearate were added and compressed 
into tablets using tablet punching machine [13, 14]. 
Preparation of tablets by dry granulation method 
All the excipients along with propranolol hydrochloride, were 
weighed in the required amount for each formulation and added into 
blender for proper mixing. The mixture was evaluated for various 
flow properties and was processed for compression. Slugging and 
deslugging were involved, followed by the lubricant addition in the 
compression of tablets using punching machine [15, 16]. 
Physical characterization of the blend 
Various techniques were employed to prepare the granules for the 
tablet. The blend for the compression of tablets was prepared using 
wet and dry granulation technique and was characterized for angle 
of repose, bulk density, compressibility index, Hausner’s ratio and 
tapped density [17-19]. 
Characterization of the prepared orodispersible tablets 
The organoleptic parameters like colour, shape and texture were 
evaluated by the senses. Size of the individual tablets out of a sample of 
20 tablets was measured using vernire caliper and it was expressed in 
mm [20]. For weight variation study of propranolol hydrochloride, 20 
tablets were randomly selected and weighed individually and weighed 
collectively too. Individual weight and average weight of tablets were 
determined. Monsanto hardness tester was used to determine the 
hardness of the tablet [21]. For the friability testing of the prepared 
tablets, roche friabilator was used. Friability of 0-1% is considered as 
acceptable range [22]. To determine the wetting time, a piece of tissue 
paper was double folded and placed in a petri plate containing 10 ml of 
water. A tablet was placed on the paper and time required for the 
completing wetting was note down [23]. Morphology of the formulated 
tablets was determined using scanning electron microscopy. Cross 
sections of the tablet were made and employed for the morphological 
determination of the developed ODTs [24]. Disintegration time of the 
tablets was determined using the method established in the USP. The 
USP disintegration apparatus used for the determination of 
disintegration time of ODTs and conventional tablets was same [25]. USP 
dissolution apparatus Type-II (paddle) was used to determine the 
percent drug release profile of the tablets in sorenson’s buffer (pH 6.8). 
Collected samples were analyzed using HPLC. Release kinetic models like 
zero order, first order, higuchi and korsmeyer pappas equations were 
used to know the pattern of release for the tablets [26, 27]. 
In vivo studies of the prepared orodispersible tablets 
Animals 
Animals used in the present investigation were procured from 
AIIMS, New Delhi. All the animals (unisex wistar rats) involved in 
the study were housed under the standard conditions and were 
provided free access to pellet, food and water. All the animals were 
divided into groups with 2 animals each (age: 4-8 w; weight: 200-
250g). The institutional animal ethical clearance (vide letter no. 
ASCB/IAEC/13/19/141) was obtained before conducting the 
studies. Group-I contained control animals; Group-II was 
administered with pure propranolol hydrochloride; group-III with 
ODTs prepared using calcium crosslinked cassia fistula gum using 
cotton method and Group-IV comprised with marketed propranolol 
hydrochloride tablets (betacap 10 mg). 
Pharmacokinetic studies 
All the animals were kept under overnight fasting before the 
experiment and food was provide post 2 h administration of the 
dosing. During the administration of tablets, animals were placed 
into animal body restraint device so that the head of the animal 
alone was exposed. Both the jaws of the mouth were separated with 
a wooden tongue pressor and tablets were placed in the mouth of 
the animals. The dose of propranolol hydrochloride was 6 mg/kg 
was employed [26, 27]. 2 ml of water was supplied as it helps in the 
disintegration of the tablet. Mouth of the animal was kept open for 1 
min using gentle strain to allow complete disintegration and 
prevention of chewing. Blood samples (0.2 ml each) were collected 
from the retro-orbital plexus/tail vein of the pre-anesthetized 
animals at the regular time intervals (0, 0.25, 0.5, 1, 2, 4, 6 and 12 h) 
after the administration of the tablet. All the collected blood samples 
were centrifuged at 3000 rpm for 10 min for the extraction of 
plasma. Drug content was analyzed using the already devloped HPLC 
method [28]. The obtained data was fitted into one compartmental 
open body model by peroral route and various pharmacokinetic 
parameters were calculated using PK solver software.  
Bio-distribution studies 
After 24 h of drug administration, animals were sacrificed and 
various body organs like brain, kidney, liver, lungs, heart and spleen 
were collected to know the amount of drug distributed to each 
organ. Collected organs were washed in normal saline and perfused 
to remove the blood traces. Homogenates were prepared in the 
saline by using a homogenizer. Drug was extracted from the 
homogenates and analyzed using HPLC method [29, 30]. 
Antihypertensive activity 
Intra-peritoneal injection of N-nitro-L-arginine methyl ester (L-
NAME) at the dose of 185 µmol/kg was used twice daily to induce 
hypertension in the wistar rats for one week. The injection volume 
was kept as 1 ml per 100 g of the animal weight. The blood pressure 
of the animals was monitored daily and the animals with systolic 
blood pressure in the range of 160-190 mm of Hg after one week of 
the L-NAME administration were labelled as the hypertensive rats 
for the antihypertensive protocols [31, 32]. The selected 
hypertensive animals were divided into a total of 3 groups of 2 
animals each (n=6), i.e. groups receiving plain propranolol 
hydrochloride, marketed product and the optimized ODT of the 
drug. One analogous control group was also maintained, animals of 
which received only distilled water. The other groups received the 
prescribed treatment at the equivalent dose of 6 mg/kg of 
propranolol hydrochloride. Subsequent to dose administration to 
study the antihypertensive effect the systolic blood pressure was 
measured at the time intervals of 0 min, 15 min, 30 min, 1 h and 2 h. 
The non-invasive tail-cuff method was employed to measure the 
systolic blood pressure of each animal at the predetermined time 
point using an experimental blood pressure system  
Stability studies 
In accordance to ICHQ1A (R2) guidelines, accelerated stability 
studies for the cotton candy ODT was performed at 40±2 °C and 
75±5% RH for 06 mo [33]. The developed ODTs packed in blister 
packs were charged for the stability studies and the observations 
were made on the basis of the disintegration time, dissolution and 
drug assay over an interval of two month. The obtained values of % 
drug assay at the three observation points. i.e. 2 mo, 4 mo and 06 mo 
were reported as per the ICH guidelines.  
RESULTS AND DISCUSSION 
Characterization of pure and crosslinked cassia fistula gum by 
FT-IR and NMR 
The FTIR spectra of the pure and crosslinked CCG gum have been 
shown in the fig. 1. The peaks observed in the region of 3500–3200 
cm−1are the characteristic absorption bands owing to the stretching 
hydroxyl groups, whereas the stretching in the range of 3000–
2850 cm−1 were result of the aliphatic stretching and the ones 
observed in the range of 1650 cm−1 were resultant of-CH-O-
strechings. These peaks are characteristic of natural gums [34]. On 
the other hand, at the wavenumbers of 1020 cm-1, 1070 cm-1, and 
1155 cm−1 the C-OH strechings due to the presence of glucan and 
mannose structures were observesd. The peaks corresponding to 
the streching of N-H and C-N at 1541 cm-1and 1080 cm−1, which 
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were conspicuous in native gum, disappeared after crosslinking. In 
the FTIR spectrum of the crosslinked gum, a higher shifting in the 
wavenumber of the absorption band at 3446 cm−1was observed. 
This peak represents the streching of-OH groups, which decreased 
substantially after cross-linking [35]. The appearance of two 
additional peaks at 1411 cm-1 and 1028 cm-1
 
 ensured the presence of 
the carboxymethyl groups in the crosslinked gum, representing the 
respective strechings of C-O and C=O groups [36]. 
 
Fig. 1: FT-IR spectra of both the native gum and the crosslinked gum 
 
The proton-NMR data have been represented in fig. 2 and fig. 3. 
Many researchers employ NMR as a tool to characterize natural 
polymers, but even the international union of pure and applied 
chemistry (IUPAC) is also of the opinion that the NMR is a 
relatively less sensitive tool to characterize the complex materials 
like natural polymers [37]. The proton NMR of the native gums 
shows the peaks-OH at 3.5 and 1-2 ppm, whereas the-OH peaks 
reflected at 3.5 ppm were absent in the NMR of the crosslinked 
polymer indicating the succesful reaction. Also the peaks between 
1.531-1.558 ppm indicated the presence of numerous protons of 






H-NMR of native cassia fistula gum 
 
Fig. 3: 1H-NMR of cross linked CCG 
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X-Ray diffraction 
The XRD pattern of pure propranolol hydrochloride, the excipients 
and the physical mixture have been shown in fig. 4. The pure drug as 
represented by fig. 4(a) is absolutely crystalline in nature, whereas 
the excipients were observed to be relatively amorphous. The 




Fig. 4: Powder X-ray diffraction pattern of (a) pure propranolol hydrochloride (b) The excipients (c) The physical mixture 
 
Differential scanning calorimetry 
In the DSC thermogram of propranolol hydrochloride a sharp 
endothermic peak at 167.56 °C represented its phase transition, i.e. 
melting point. The excipients were found to be compatible with the 
drug as the melting point range of the drug remained same as 
depicted in fig. 5. 
Flow properties of the blends 
For the wet and dry granulation, process blends were prepared and 
were analyzed for flow properties. Blend of both wet and dry 
granulation was shown in table 2. Both cotton candy and 
lyophilization methods does not require any flowability henceforth, 
these parameters were not evaluated. Evaluated flow parameters of 
the powder blend were reported in table 3 [39]. 
Compatibility studies 
As shown in fig. 6, there is neither appearance of any new peak 
nor the disappearance of the older peak in the FT-IR spectrum. 
Henceforth, it was concluded that there were no any 
compatibility issues of the drug with the selected excipients of 
the final ODT. 
 
 
Fig. 5: DSC thermogram of the plain propranolol hydrochloride, excipients and physical mixture of the excipient and the drug 
 
Table 3: Flow properties of various powder blends used for the development of tablets by wet/dry granulation technique 
Wet granulation technique 
Formulation code Angle of repose ( °) Bulk density (g/cm3 Tapped density (g/cm) 3 Carr’s index (%) ) Hausner’s ratio 
PW1 23.24±0.32 0.49±0.037 0.54±0.041 9.3±0.61 1.12±0.07 
PW2 22.16±0.37 0.54±0.021 0.63±0.038 14.5±0.57 1.17±0.06 
PW3 24.03±0.41 0.37±0.026 0.44±0.027 15.1±0.39 1.19±0.04 
PW4 23.71±0.29 0.42±0.031 0.44±0.031 4.6±0.48 1.07±0.09 
PW5 22.98±0.30 0.48±0.042 0.53±0.033 9.5±0.51 1.11±0.05 
PW6 22.67±0.27 0.51±0.039 0.54±0.040 5.6±0.41 1.07±0.04 
Dry granulation technique 
PD1 22.91±0.37 0.47±0.068 0.52±0.029 9.7±0.37 1.12±0.01 
PD2 22.47±0.26 0.52±0.043 0.56±0.031 7.2±0.49 1.09±0.09 
PD3 24.31±0.49 0.41±0.072 0.46±0.044 10.9±0.51 1.13±0.05 
PD4 23.76±0.51 0.47±0.052 0.50±0.047 6.3±0.29 1.08±0.04 
PD5 21.83±0.44 0.56±0.049 0.65±0.051 13.9±0.31 1.17±0.03 
PD6 24.32±0.36 0.39±0.052 0.40±0.032 2.5±0.40 1.04±0.06 
mean±SD, n=3 SD=standard deviation 
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Fig. 6: FTIR (a) Propranolol hydrochloride (b) Mixture with the excipients 
 
Characterization of the developed tablets 
Physical evaluation of the tablets developed by wet/dry 
granulation 
Thickness, diameter, hardness, weight variation and % friability of 
the developed tablets through dry and wet granulation techniques 
were shown in table 4. 
Physical evaluation of ODTs developed by lyophilization and 
cotton candy process 
Diameter, thickness, hardness, % friability and weight variation of 
tablets from all the lots of lyophilization method and cotton candy 
method were analysed and reported in table 5. 
Evaluation of the developed propranolol hydrochloride loaded 
ODTs 
Wetting time and disintegration time of the developed ODTs 
employing various methods were displayed in table 6. On the basis 
of the result obtained by lyophilization,dry granulation,wet 
granulation and cotton candy process formulations coded as PL8, 
PD2, PW2 and PC1 respectively were selected for further 
exploration. These results suggested that progress in drug release 
[13, 14]. From content uniformity assay it was found that all, the 
developed systems were showing the results in the prescribed limit. 
The assay of drug content showed that all the products contain more 
than 98.2% of drug. Based on the wetting and disintegration time of 
the all the developed lots, best four promising formulations were 
selected for further studies. PD2 and PW2 formulations of dry and 
wet granulation method, PL8 of lyophilization method and PC1 of 
cotton candy method was selected. Drug release profile of all these 
four formulations was observed and further one promising 
formulation which showed better release was used for in vivo 
pharmacokinetic evaluation. All four selected formulations have 
been highlighted in the tablet 6. 
In vitro drug release studies 
Drug release profile of propranolol hydrochloride ODTs coding PC1, 
PL8, PW2 and PD2 was shown in fig. 7. The drug release profile 
ranged from 59.9% to 88.2% in 10 min after adding the tablets to 
the dissolution media i. e Sorenson buffer pH 6.8 which is similar to 
the saliva. From the study, it was found that cotton candy method 
resulted in the formulation which can yield a high amount of drug 
release which may be ascribed due to the high amount of sugars. 
Next to this method, product obtained through lyophilization 
method showed better results, which were due to high amounts of 
mannitol used in the formulation process. The drug release pattern 
was shown as PC1>PL8>PW2>PD2. 
Formation of hydrotropic dispersion and the molecular dispersion 
within the tablet matrix helped in achieving the desired drug release 
pattern. 
  
Table 4: Evaluation of developed tablets by wet/dry granulation technique 
Wet granulation technique  
Formulation code Thickness (mm)±SD Hardness (kg/cm2 Weight variation (mg) ) % Friability %Drug content 
PW1 2.3±0.04 2.5±0.1 100±0.29 0.49±0.08  97.2±0.23 
PW2 2.4±0.02 2.3±0.2 99±0.42 0.56±0.13 98.4±0.25 
PW3 2.1±0.01 2.4±0.1 100±0.17 0.62±0.06  96.9±0.32 
PW4 2.4±0.03 2.4±0.1 101±0.31 0.39±0.08 100.2±0.32 
PW5 2.3±0.02 2.3±0.2 99±0.50 0.41±0.10 100.8±0.23 
PW6 2.2±0.04 2.2±0.1 100±0. 34 0.52±0.08 99.2±0.31 
Dry granulation technique  
PD1 2.4±0.03 2.3±0.1 99±0.32 0.51±0.11 97.7±0.59 
PD2 2.5±0.04 2.2±0.1 100±0.46 0.47±0.11 97.2±0.34 
PD3 2.3±0.02 2.2±0.1 101±0.33 0.55±0.10 99.4±0.35 
PD4 2.0±0.04 2.3±0.1 99±0.49 0.37±0.15 98.3±0.39 
PD5 2.3±0.05 2.4±0.2 100±0.21 0.41±0.09 98.9±0.24 
PD6 2.2±0.03 2.2±0.1 100±0.35 0.62±0.13 97.5±0.21 
mean±SD, n=3 
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Table 5: Evaluation of developed tablets by lyophilization and cotton candy method 
Lyophilization method 
Formulation code Thickness (mm)±SD Hardness (kg/cm2 Weight variation (mg) ) % Friability %Drug content 
PL1 4.4±0.06 2.4±0.2 230±1.43 0.51±0.09  98.2±0.25 
PL2 4.8±0.04 2.3±0.2 319±2.18 0.55±0.13 97.4±0.23 
PL3 5.2±0.03 2.2±0.4 369±2.59 0.68±0.07  96.9±0.35 
PL4 5.4±0.07 2.3±0.5 421±3.34 0.43±0.08 99.3±0.32 
PL5 4.3±0.05 2.6±0.2 229±2.07 0.44±0.10 100.8±0.31 
PL6 4.9±0.03 2.4±0.1 320±3.12 0.54±0.09 99.6±0.29 
PL7 5.3±0.07 2.3±0.6 379±4.77 0.64±0.08 98.8±0.32 
PL8 5.5±0.05 2.4±0.5 418±4.91 0.65±0.09 97.2±0.41 
Cotton candy method 
PC1 4.2±0.05 2.2±0.1 224±2.6 0.34±0.06 99.8±0.43 
PC2 4.1±0.03 2.3±0.1 225±2.3 0.37±0.09 98.6±0.36 
mean±SD, n=3  
 
Table 6: Wetting time and disintegration time of various formulations prepared by different methods 
Lyophilization method 
Code Wetting time (s) Disintegrating time (s) 
PL1 19.2±1.1 31.9±2.1 
PL2 24.1±1.6 29.2±1.9 
PL3 20.9±1.3 26.9±1.6 
PL4 25.6±1.3 31.6±2.2 
PL5 18.7±1.3 24.7±1.4 
PL6 21.4±0.8 27.4±1.6 
PL7 26.7±1.7 32.5±2.1 
PL8 14.4±0.6 19.2±0.7 
Dry granulation technique 
PD1 14.2±0.7 21.3±1.2 
PD2 15.7±1.0 22.8±0.8 
PD3 19.6±1.2 26.5±1.3 
PD4 21.4±0.9 28.4±1.9 
PD5 20.5±1.1 27.9±1.7 
PD6 24.3±1.2 31.2±2.4 
Wet granulation technique 
PW1 21.4±1.3 27.6±1.1 
PW2 14.6±1.1 21.5±1.0 
PW3 17.3±1.2 27.1±1.8 
PW4 22.8±1.0 29.8±1.9 
PW5 23.4±1.2 31.6±2.0 
PW6 28.3±2.1 35.1±2.4 
Cotton candy method 
PC1 12.5±0.8 18.9±0.4 
PC2 23.2±2.6 39.6±2.9 
mean±SD, n=3  
 
 
Fig. 7: Drug release profile of propranolol hydrochloride ODT 
code PC1, code PL8, code PW2 and code PD2, [mean±SD, n=3] 
The data of the drug release from the formulation was fitted in zero 
order, first order, higuchi and korsmeyer peppas models to find the 
best fitted one by using the values of the coefficient of determination 
(r2
Scanning electron microscopy 
). The obtained values confirm that the developed systems offerd 
korsmeyer's-peppas drug release profile. This model represents that 
the drug release from the tablets was due to the erosion of the 
polymer layer (sugars in this formulations) along with matrix 
swelling resulting in the drug dissolution.  
Fig. 8 (a) and fig. 8 (b) show the SEM images of the pre-compressed 
and post-compressed powder for the propranolol hydrochloride 
ODT. As it is conspicuous that the powder material was segregated 
prior to processing, which has come closer after the formulation 
leading to the formation of a single unit dose. 
 
 
Fig. 8 (a): SEM of the pre-mix for the propranolol hydrochloride ODT Fig. 8 (b): SEM image of the final propranolol hydrochloride ODT 
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Fig. 9: The graph between plasma concentrations of propranolol hydrochloride in the rats receiving various treatments as a function of 
time, [mean±SD, n=3] 
 
Pharmacokinetic studies 
Fig. 9 portray the pharmacokinetic profile of the propranolol 
hydrochloride through the PC1 formulation of the cotton candy 
process which was selected from the drug release results. 
From the graph, it was clear that the concentration of propranolol 
hydrochloride was high at every point in the plasma sample 
collected from the animals treated with the formulation prepared by 
cotton candy technique rather than the plain drug and marketed 
product. There was a significant difference in the concentration 
profile of both groups (p<0.05). This difference supports the 
advantage of developing a formulation and site of absorption of drug 
in the GIT.  
In vivo absorption studies 
Obtained pharmacokinetic parameters were fitted in one CBM per 
oral model. From the results, it was found that the rate of 
elimination (K) was decreased by 4.25 times with the increase in 
plasma maximum concentration (Cmax
Biodistribution studies  
) resulted in the enhanced 
residence time of the drug within the biological system. Residence 
time of the drug in the body is represented by mean residence time 
(MRT), which was increased after the development of ODTs vis-à-vis 
plain drug. It was vivid from the area under the plasma 
concentration-time curve (AUC) that there was increase in 
bioavailability of the drug by almost 2.4 folds after the 
manufacturing process. These results proved that the development 
of ODTs helped in reducing the hepatic metabolism of the drug 
caused due to CYP3A4 enzyme. This may be due to the skipping of 
the hepatic portal system by the ODTs during the process of the drug 
absorption resulting in enhanced bioavailability.  
Fig. 10 displays the bar diagram showing the amount of drug 
present in each organ. This is a single point biodistribution study. 
 
 
Fig. 10: The concentration of propranolol hydrochloride per gram of the organ mentioned after 24 h of dose administration, [mean±SD, 
n=3] 
 
From the bar diagram shown in fig. 10, it was observed that the 
change in the amount of drug in animal groups was similar other 
than lungs and brain. The amount of drug in the liver and spleen is 
reduced in the animals treated with ODTs vis-à-vis plain drug 
(p<0.05). This result supports the pharmacokinetic profile of the 
ODTs as the drug availability is minimal at the site with microsomal 
enzymes. This indicates that the ODTs developed were absorbed 
through the buccal cavity, which helps to overcome the hepatic 
metabolism. This leads to an increase in the plasma concentration of 
the drug, which directly affects the pharmacological profile of the 
developed ODTs. These in vivo studies helped in the effective 
delivery of propranolol hydrochloride by developing the ODTs. 
Antihypertensive activity 
The results obtained from the antihypertensive pharmacological 
studies measuring the systolic pressure of the rats at various time 
points has been shown in fig. 11. The normal systolic pressure of the 
rats is 118.5±2.09 mm of Hg. However, the average systolic pressure 
in the disease control i.e. the hypertensive rat group not receiving 
any treatment, was observed to be around 180 mm of Hg vouching 
for the successful induction of the diseased state. From the observed 
data, it can be easily inferred that the reduction in the blood 
pressure was more pronounced in the group receiving optimized 
ODT (PC1) product vis-à-vis marketed product as well plain drug at 
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p<0.05. In a shorter duration of 15 min, the animals receiving the 
propranolol hydrochloride-loaded ODT exhibited a substantial 
reduction in the systemic blood pressure whereas the equivalent 
effect was observed in the marketed product receiving animal group 
at 60 min. The data unequivocally established the superiority of the 
developed system over the marketed product as well as the plain 
drug. The enhanced pharmacodynamic response of the developed 
system can be ascribed to the faster rates of absorption and slower 
elimination coupled with lower Tmax and elevated Cmax 
  
as inferred 
from the pharmacokinetic studies. 
 
Fig. 11: Graph showing the pattern of systolic blood pressure in the various treatment groups [mean±SD, n=3] 
 
Stability studies 
The selected cotton candy based propranolol hydrochloride loaded 
ODT offered the best physicochemical and the biological outcomes in 
the real time scenario. Over the 6 mo accelerated stability 
assessment it was observed that no variation in the physical 
appearance and other studied parameters was observed, as shown 
in table 12. 
 
Table 12: Accelerated stability data of the optimized ODT product (PC1) over a period of six months 
Parameters  D  
0  30  45  60  90  120  150  180  
Physical 
appearance  
No Change  No Change  No Change  No Change  No Change  No Change  No Change  No 
Change  
Weight  224 ± 2.6  224.3 ± 1.26  223.3 ± 1.48  223.6 ± 2.26  223.9 ± 1.49  224.6 ± 1.45  224.9 ± 2.38  224.3 ± 
1.37  
Hardness  2.2±0.1  2.2±0.4  2.1±0.2  2.1±0.7  2.1±0.5  2.1±0.3  2.0±0.4  2.0±0.2  
Friability  0.34±0.06  0.34±0.09  0.35±0.03  0.35±0.05  0.35±0.09  0.36±0.06  0.36±0.02  0.36±0.08  
Disintegration  18.9 ± 0.4  19.1 ± 0.2  19.4 ± 0.5  19.5 ± 0.8  19.9 ± 0.4  20.2 ± 0.3  20.6 ± 0.8  20.7 ± 0.3  
Drug content 99.8±0.43 99.6±0.39 99.5±0.26 99.2±0.41 99.2±0.28 98.9±0.27 98.6±0.58 98.4±0.31 
[mean±SD, n=3]  
 
CONCLUSION 
This research manuscript clearly shows the successful development of 
the ODTs loaded with an antihypertensive drug namely propranolol 
hydrochloride. In this process of development of the ODTs, a novel 
superdisintegrant was also developed which enhanced the efficiency 
of the ODTs. It was unequivocally understood that cotton candy 
method can be a best option for the development of drug-loaded ODTs. 
This was enhanced bioavailability and the efficacy of the propranolol 
hydrochloride after preparation of ODTs. The drug loaded ODTs 
helped in the effective reduction of the drug entering the liver. This 
indeed can reduce the hepatic metabolism. In considering all these 
achievements, it can be concluded that this new form of oral drug 
delivery system can be ray of hope for scientists to deliver the drugs 
with high patient compliance.  
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